IAVI - Policy Research

Skip to main content

> > > >

Policy Research

This database contains research and analysis by experts at IAVI and its partners on policy issues relevant to AIDS vaccine research and development.

Page

Study Name	Study Summary
Enhancing Brazil’s Capacity for Biopharmaceutical Innovation	Targeted policy reforms could accelerate Brazil’s participation in AIDS vaccine R&D. This study identifies obstacles and recommendations to advancing AIDS vaccine R&D in Brazil.
Estimating the Potential Impact of an AIDS Vaccine in Developing Countries	An AIDS vaccine could drastically reduce the number of new HIV infections in low- and middle-income countries. This study explores the potential epidemiological impact of a future AIDS vaccine as part of a comprehensive response to the AIDS pandemic.
Monitoring Trends in HIV Prevention Research Funding	This ongoing collaborative study by the HIV Vaccines and Microbicides Resource Tracking Working Group provides data on HIV vaccine R&D funding trends, which can enable a systematic monitoring of investment in new HIV-prevention strategies and the identification of important new trends.
Opportunities for Accelerating AIDS Vaccine R&D in China	China is poised to assume greater leadership in one of the most important intersections of public health and innovation: the development of a vaccine to prevent HIV infection. This study examines the policy environment for AIDS vaccine R&D in China and identifies policies that could bolster the country’s efforts in that field of research.
R&D Models: Lessons from Vaccine History	Progress toward an AIDS vaccine depends on management and scale of effort in addition to resources and science. This report examines the history of vaccine development and provides examples of large R&D initiatives in other areas in order to better understand the roles of public and private sectors and merits and risks of strong central direction of R&D in the quest for an AIDS vaccine.

1 of 2 Next